|
BBS4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.235700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.870300E-02 |
| Normal-vs-Stage2 |
1.847580E-01 |
| Normal-vs-Stage3 |
8.404000E-01 |
| Normal-vs-Stage4 |
8.351200E-01 |
| Stage1-vs-Stage2 |
8.253200E-01 |
| Stage1-vs-Stage3 |
1.350420E-01 |
| Stage1-vs-Stage4 |
4.952400E-01 |
| Stage2-vs-Stage3 |
1.858830E-01 |
| Stage2-vs-Stage4 |
4.484800E-01 |
| Stage3-vs-Stage4 |
7.659000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.644600E-03 |
| Normal-vs-AfricanAmerican |
1.682840E-01 |
| Normal-vs-Asian |
3.158200E-01 |
| Caucasian-vs-AfricanAmerican |
5.123000E-01 |
| Caucasian-vs-Asian |
1.980640E-01 |
| AfricanAmerican-vs-Asian |
2.725000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.271890E-02 |
| Normal-vs-Female |
1.002380E-01 |
| Male-vs-Female |
7.411600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.643000E-01 |
| Normal-vs-Extreme_Weight |
3.569800E-02 |
| Normal-vs-Obese |
4.969700E-02 |
| Normal-vs-Extreme_Obese |
5.582200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.245800E-01 |
| Normal_Weight-vs-Obese |
2.288600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.494200E-01 |
| Extreme_Weight-vs-Obese |
9.870400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.022200E-01 |
| Obese-vs-Extreme_Obese |
6.943400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.003400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.834900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.573040E-01 |
| Normal-vs-Age(81-100Yrs) |
9.649200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.312000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.877800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.120000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.205800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.008160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.275800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.74823999999907E-05 |
| Normal-VS-Type2 PRCC |
4.798000E-01 |
| Normal-VS-KIRP CIMP |
1.938700E-03 |
| Normal-VS-Unclassified PRCC |
3.840400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.1637999999834E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.18069999996717E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
3.516400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.547940E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.546160E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.23290000000476E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.394400E-01 |
| Normal-vs-N1 |
2.825600E-01 |
| Normal-vs-N2 |
9.083200E-01 |
| N0-vs-N1 |
1.898550E-01 |
| N0-vs-N2 |
8.021600E-01 |
| N1-vs-N2 |
6.904200E-01 |
|
|
